X-54809979-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP7
The NM_177433.3(MAGED2):āc.303T>Cā(p.Ser101=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000025 in 1,200,816 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000092 ( 0 hom., 1 hem., cov: 21)
Exomes š: 0.0000018 ( 0 hom. 1 hem. )
Consequence
MAGED2
NM_177433.3 synonymous
NM_177433.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.434
Genes affected
MAGED2 (HGNC:16353): (MAGE family member D2) This gene is a member of the MAGED gene family. The MAGED genes are clustered on chromosome Xp11. This gene is located in Xp11.2, a hot spot for X-linked intellectual disability (XLID). Mutations in this gene cause a form of transient antenatal Bartter's syndrome. This gene may also be involved in several types of cancer, including breast cancer and melanoma. The protein encoded by this gene is progressively recruited from the cytoplasm to the nucleoplasm during the interphase and after nucleolar stress and is thus thought to play a role in cell cycle regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP7
Synonymous conserved (PhyloP=0.434 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGED2 | NM_177433.3 | c.303T>C | p.Ser101= | synonymous_variant | 3/13 | ENST00000375068.6 | NP_803182.1 | |
MAGED2 | NM_014599.6 | c.303T>C | p.Ser101= | synonymous_variant | 3/13 | NP_055414.2 | ||
MAGED2 | NM_201222.3 | c.303T>C | p.Ser101= | synonymous_variant | 3/13 | NP_957516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGED2 | ENST00000375068.6 | c.303T>C | p.Ser101= | synonymous_variant | 3/13 | 1 | NM_177433.3 | ENSP00000364209 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000918 AC: 1AN: 108948Hom.: 0 Cov.: 21 AF XY: 0.0000316 AC XY: 1AN XY: 31642
GnomAD3 genomes
AF:
AC:
1
AN:
108948
Hom.:
Cov.:
21
AF XY:
AC XY:
1
AN XY:
31642
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000183 AC: 2AN: 1091868Hom.: 0 Cov.: 33 AF XY: 0.00000279 AC XY: 1AN XY: 358166
GnomAD4 exome
AF:
AC:
2
AN:
1091868
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
358166
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000918 AC: 1AN: 108948Hom.: 0 Cov.: 21 AF XY: 0.0000316 AC XY: 1AN XY: 31642
GnomAD4 genome
AF:
AC:
1
AN:
108948
Hom.:
Cov.:
21
AF XY:
AC XY:
1
AN XY:
31642
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 03, 2022 | This sequence change affects codon 101 of the MAGED2 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the MAGED2 protein. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with MAGED2-related conditions. This variant is not present in population databases (gnomAD no frequency). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at